These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12166941)

  • 1. Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines.
    Yu QS; Zhu X; Holloway HW; Whittaker NF; Brossi A; Greig NH
    J Med Chem; 2002 Aug; 45(17):3684-91. PubMed ID: 12166941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
    Zhan ZJ; Bian HL; Wang JW; Shan WG
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.
    Yu Q; Holloway HW; Flippen-Anderson JL; Hoffman B; Brossi A; Greig NH
    J Med Chem; 2001 Nov; 44(24):4062-71. PubMed ID: 11708910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
    Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
    J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis-huperzine B: highly potent and selective acetylcholinesterase inhibitors.
    Feng S; Wang Z; He X; Zheng S; Xia Y; Jiang H; Tang X; Bai D
    J Med Chem; 2005 Feb; 48(3):655-7. PubMed ID: 15689148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anticholinesterase activity of new substituted benzo[d]oxazole-based derivatives.
    Pouramiri B; Moghimi S; Mahdavi M; Nadri H; Moradi A; Tavakolinejad-Kermani E; Firoozpour L; Asadipour A; Foroumadi A
    Chem Biol Drug Des; 2017 May; 89(5):783-789. PubMed ID: 27863021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors.
    Tang H; Ning FX; Wei YB; Huang SL; Huang ZS; Chan AS; Gu LQ
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3765-8. PubMed ID: 17451950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Mughal EU; Sadiq A; Murtaza S; Rafique H; Zafar MN; Riaz T; Khan BA; Hameed A; Khan KM
    Bioorg Med Chem; 2017 Jan; 25(1):100-106. PubMed ID: 27780618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
    Luo W; Yu QS; Zhan M; Parrish D; Deschamps JR; Kulkarni SS; Holloway HW; Alley GM; Lahiri DK; Brossi A; Greig NH
    J Med Chem; 2005 Feb; 48(4):986-94. PubMed ID: 15715468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on dual-site inhibitors of acetylcholinesterase: Highly potent derivatives of bis- and bifunctional huperzine B.
    He XC; Feng S; Wang ZF; Shi Y; Zheng S; Xia Y; Jiang H; Tang XC; Bai D
    Bioorg Med Chem; 2007 Feb; 15(3):1394-408. PubMed ID: 17126020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation at C-16 enhances butyrylcholinesterase inhibition in lupane triterpenoids.
    Castro MJ; Richmond V; Faraoni MB; Murray AP
    Bioorg Chem; 2018 Sep; 79():301-309. PubMed ID: 29793143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugates of Tacrine and Its Cyclic Homologues with p-Toluenesulfonamide as Novel Acetylcholinesterase and Butyrylcholinesterase Inhibitors.
    Makhaeva GF; Kovaleva NV; Lushchekina SV; Rudakova EV; Boltneva NP; Proshin AN; Lednev BV; Serkov IV; Bachurin SO
    Dokl Biochem Biophys; 2018 Nov; 483(1):369-373. PubMed ID: 30607741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine.
    Decker M
    Eur J Med Chem; 2005 Mar; 40(3):305-13. PubMed ID: 15725500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine.
    Yu QS; Holloway HW; Luo W; Lahiri DK; Brossi A; Greig NH
    Bioorg Med Chem; 2010 Jul; 18(13):4687-93. PubMed ID: 20627738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues.
    Yu QS; Pei XF; Holloway HW; Greig NH; Brossi A
    J Med Chem; 1997 Aug; 40(18):2895-901. PubMed ID: 9288171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oxidation products of melatonin derivatives exhibit acetylcholinesterase and butyrylcholinesterase inhibitory activity.
    Siwicka A; Moleda Z; Wojtasiewicz K; Zawadzka A; Maurin JK; Panasiewicz M; Pacuszka T; Czarnocki Z
    J Pineal Res; 2008 Aug; 45(1):40-9. PubMed ID: 18284552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.